Neuromodulation and Exercise Treatment Effects on Pain and Function in Adults Aged 25 to 35 With Fibromyalgia Syndrome

What this Trial Is About

Fibromyalgia Syndrome is a common musculoskeletal condition affecting mostly adults aged 40-60, with a higher occurrence in women. Researchers are studying how non-invasive neuromodulation combined with exercises impacts pain biomarkers and functional outcomes in patients aged 25 to 35 with fibromyalgia. The goal is to understand the effects of this treatment approach on pain and overall function. Participants are randomly assigned to one of two groups. One group receives aerobic exercises along with sham non-invasive neuromodulation, while the other group performs the same exercises combined with active non-invasive neuromodulation. Treatments are given three times per week for one hour each session over four weeks. The neuromodulation involves transcutaneous electrical nerve stimulation applied for 30 minutes per session. During the study, participants will undergo assessments including the Numeric Pain Rating Scale, biochemical analysis, the Fibromyalgia Impact Questionnaire, and pressure pain thresholds, all measured after four weeks. These evaluations help track changes in pain and function. The study is double-blinded, and participation includes close monitoring during the treatment period to ensure safety and adherence.

Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome